Objective: The objective of this study is to investigate the relationship between glycemic status and severe retinopathy of prematurity (ROP).
Introduction
Extremely low birth weight (ELBW) infants (<1000 g) are at high risk to develop glucose instability during their early neonatal intensive care unit (NICU) course, 1, 2 although the risk decreases with increasing gestational age (GA). 1 Identification of the consequences of early glucose intolerance is complicated by the lack of definitions for hypo-and hyperglycemia in ELBW infants. 3 Renal glucose excretion and neurological signs have been used as indicators of significant hyperglycemia and hypoglycemia, respectively; however, these findings are often misleading because of other physiological abnormalities. 4, 5 Retinopathy of prematurity (ROP) is a vasoproliferative disorder linked to early exposure to relatively high retinal oxygen levels, 6, 7 with an incidence of >50% in ELBW infants. 8 Recently, high glucose levels have been associated with an increased ROP incidence in ELBW infants. 1, 9, 10 However, there is no evidence demonstrating a direct cause-effect relationship. The lack of an accepted severity of illness score for newborns after the first 24 h of life 11 complicates interpretation of the data, as glucose instability can be an expression of severity of illness, 12, 13 which may be the risk factor for ROP. Several studies have described similarities between oxygeninduced retinopathy (ROP) and glucose-induced diabetic retinopathy. 14, 15 Given these data, we hypothesized that, rather than being caused by a single random event of glucose instability, the development of ROP in ELBW is caused by a dysregulation of glycemic status with persistently higher glucose levels in those infants with severe ROP. Therefore, we carried out a retrospective analysis of data from a cohort of ELBW infants to determine the relationship between glycemic status and development of severe ROP.
Methods

This study complied with the Guidelines for Human
Experimentation from the US Department of Health and Human Services and was approved by The Johns Hopkins Hospital Institutional Review Board. As data were de-identified, no parental informed consent was required.
All infants <1000 g born in or transferred to the Johns Hopkins Hospital NICU between March 1 2004 and February 28 2007 were included. Any infant X48 h old at time of transfer as well as infants who did not survive beyond 10 days of life and those for whom glucose levels or ROP status were not available were excluded, as were babies with major genetic disorders or malformations, intrauterine growth restriction or suspected viral infection.
Demographic, perinatal and laboratory data were collected from electronic and paper chart records. After a master database was created, all identifiers such as name, address, phone number, transferring hospital and date of birth were permanently removed from the database. GA and Apgar scores were determined by the NICU team during the initial neonatal assessment. Race was assigned based on maternal race. Premature prolonged rupture of membranes was defined as rupture for X18 h at <37 weeks GA or as recorded in the chart. A clinical risk index for babies (CRIB) score was calculated to assess severity of illness at 12 h after birth.
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Because infants with anomalies and neonatal deaths were excluded from the analysis, the highest possible CRIB score was 20 out of 23 in this cohort. Duration of invasive mechanical ventilation and inotrope administration was determined by counting the number of days on therapy. Inotrope administration was used as a surrogate for hypotension. Analysis of partial arterial oxygen pressure (PaO 2 ), measured in blood collected from umbilical or peripheral arterial lines, was limited to the first 10 days of life because of the availability of the data. Daily maximum and daily mean PaO 2 levels were averaged for the first 10 days of life and used for analysis. Bronchopulmonary dysplasia (BPD) was defined as the need for supplemental oxygen at 36 weeks corrected postmenstrual age or at discharge from the NICU, whichever came first. 16 The physiological room air challenge to confirm the diagnosis of BPD was not in use during the study period. Other therapies such as insulin, postnatal steroids (dexamethasone, hydrocortisone or both) and diuretics (furosemide, chlorothiazide or both) were also analyzed. Indomethacin or ibuprofen treatment was used as a surrogate for clinical patent ductus arteriosus (PDA). Use of indomethacin for PDA or intraventricular hemorrhage (IVH) prophylaxis was not a common practice in the Johns Hopkins NICU during the study period; however, if indomethacin therapy was initiated during the first day of life, the infant was considered to have PDA only if therapy extended beyond the third day of life. Infection was confirmed by any positive blood, cerebrospinal fluid or urine culture and categorized by organism (bacterial (gram positive or negative), fungal or viral). Results of PCR testing for herpes simplex virus were not available for analysis; therefore, surface cultures results were reviewed. IVH was graded by routine head ultrasound using Papile's classification from grade 1 to 4. 17 For purposes of analysis, infants were classified as severe if the highest IVH grade (unilateral or bilateral) was 3 or 4, or if periventricular leukomalacia (PVL) was reported.
ROP was evaluated at 4 to 6 weeks of age for all included infants with follow-up as recommended by the national guidelines. 18, 19 For purposes of initial analysis ROP was classified as (1) no ROP, (2) mild ROP (stage 1 or 2, zone II or III) and (3) severe ROP (any ROP in zone I, or stage 3 or greater in any zone, and/or the presence of plus disease, retinal detachment or need for treatment). The worst ROP severity during hospital course was recorded for analysis purposes. Preliminary analysis did not show a correlation between stage of ROP alone and TWGL. As initial multinomial analysis by severity of disease showed no difference in TGWL between no ROP and mild ROP groups, we collapsed these two categories into a 'non-severe' ROP classification for binomial analysis (Supplementary Figure 1A) .
Analysis of glucose levels using retrospective data is subject to bias, because patients with 'abnormal' glucose values are more likely to receive immediate follow-up testing. Therefore, the use of average glucose could skew the observation toward outliers. To obviate this problem, we determined a time-weighted glucose levels (TWGLs) or area under the curve as a representation of glycemic status (Figure 1a ). To increase accuracy and refine the area under the curve, we chose to include all values, both, those determined on serum and those obtained using point of care testing on whole blood (accucheck). From 86 056 glucose data points available, 51 171 were included in the final database after removing duplicates and of those almost two-thirds (32 137) were bedside whole-blood glucose measurements. An average ( ± s.d.) of 8 ( ± 3) and 6 ( ± 3) glucose data points were available per infant per day during the first 10 and 30 days of life, respectively. The number of glucose data points used to generate the TWGL was similar between infant that developed non-severe and severe ROP (Supplementary Figure 1B) . A daily TWGL was generated by dividing the sum of all products by 1440 (number of minutes per day). Daily TWGLs during the first 10 days (10 days TWGL) and 30 days (30 days TWGL) of life were plotted by ROP severity. Percentiles were used to stratify the 10 days TWGL and 30 days TWGL data for univariate logistic regression to transform the continuous variable to binary. Glucose data was also examined to determine the frequency of levels X150 or 200 mg dl
À1
(hyperglycemia) and p40 or 50 mg dl À1 (hypoglycemia). Single, multiple and combined events of 'hyperglycemia' and/or 'hypoglycemia' during the first 10 days and 30 days of life were analyzed by univariate logistic regression to predict severe ROP. Transitions between 'hyperglycemia' and 'hypoglycemia' in either direction with no 'normoglycemia' between data points, the number of 1 h events of either during the first 10 days, and the total duration of 'hyperglycemia' or 'hypoglycemia' during the first 10 days of life were also analyzed separately.
Statistical methods
Categorical variables were compared using w 2 -test. Continuous variables with normal distribution are reported as mean±s.d. and analyzed using unpaired t-test, while those not normally distributed are reported as median with interquartile range (25th to 75th percentile) and analyzed by Mann-Whitney U-test. Repeated measures analysis of variance (ANOVA) or KruskalWallis test was used for analysis of more than two groups. Univariate regression was followed by multivariate logistic regression using a backward stepwise approach by likelihood ratio. As all glucose-related factors are derived from the same data, those reaching significance by univariate regression (Pp0.10) were analyzed in separate multivariate models. Steroid treatment (one versus multiple postnatal steroid types) and confirmed infection (any versus kind) data were analyzed similarly. Except for the univariate logistic regression, significance was determined by P<0.05. The resulting adjusted odds ratios (ORs) of the different logistic models were weighted based on the proximity of the 95% confidence interval to 1. An adjusted OR with a lower bound the farthest from 1 was considered the 'best' and the closest to 1 was considered the 'worst'. SPSS 18.0 software (SPSS, Chicago, IL, USA) was used for analysis.
Results
During the study period, 167 ELBW infants were admitted to the Johns Hopkins NICU. From those, 53 (32%) infants were excluded for reasons described in Figure 1b . The 114 ELBW infants included for final analysis were (mean ± s.d.) GA 26.6 ± 2 weeks, birth weight 782±136 g, 54% were males and 58% were AfricanAmerican (Table 1) . Among these infants, 64 (56%) had no evidence of ROP, 33 (29%) had mild ROP and 17 (15%) had severe ROP. Demographic characteristics were not different between infants developing non-severe and severe ROP (Table 1) . Similarly, clinical characteristics such as incidence of premature prolonged rupture of membranes, CRIB score, diagnosis of BPD, IVH, gram negative or fungal sepsis and insulin treatment were not different between infants who developed severe ROP and those who did not (Table 1 ). In contrast, infants who developed severe ROP did have Table 1 ). The plots generated by daily average and maximum PaO 2 during first 10 days of life showed no significant difference between ROP severity groups (Figures 2a  and b ). Diuretics such as furosemide (Lasix, Sanofi-Aventis US.LLC, Bridgewater, NJ, USA) or chlorothiazide (Diuril, Lundbeck, Deerfield, IL, USA) were used in all infants included in this study with at least one dose administered during the first 30 days of life. PDA was medically treated in 41 infants (36%) with no difference between the two study groups.
Multiple approaches were used to analyze the glucose data. Episodes of glucose X200 and p40 mg dl À1 were not analyzed because of the low frequency of these events. One or more glucose levels p50 mg dl À1 was found less frequently in infants with severe ROP (77 versus 35%, P ¼ 0.001); however, the frequency of levels X150 mg dl À1 was not different between groups (Table 1) . Transitions between low and high glucose levels were also not found to be significant. In our cohort, the average TWGL was significantly higher during the first 10 days of life than in all subsequent periods of time (104±21 mg dl À1 at 0 to 9 days of life, 96 ± 14 mg dl À1 at 10 to 29 days of life and 89 ± 15 mg dl À1 at 30 days to length of stay; P<0.001, Supplementary Figure 2A When plotted over time, the distribution of the daily average TWGL showed that infants who developed severe ROP had a higher overall glycemic status (P ¼ 0.02), with larger difference during the first 10 days of life (P<0.01, Figure 2c ). For subsequent analyses we categorized TGWL by percentiles (Supplementary Table  A) . Ten-days TWGL X100 mg dl À1 (50th percentile) and 30 days TWGL X118 mg dl À1 (90th percentile) were more frequently observed in infants developing severe ROP (P<0.01 and P<0.05, respectively; Table 1 ). Once again, stratification of those infants with non-severe disease showed that those with no ROP and mild ROP had the same incidence of 10 days TWGL X100 mg dl À1 (46.9 and 48.5%, respectively).
Univariate logistic regression to predict severe ROP included all demographic, clinical and glucose data described above. Factors associated with severity of illness such as hypotension, infection and use of steroids reached significance. Ten-days TWGL X100 mg dl À1 and 30 days TWGL X118 mg dl À1 also reached significance (OR 5.17 (1.40 to 19.16, P ¼ 0.01) and 5.70 (1.34 to 23.8, P ¼ 0.02), respectively; Table 2a ). Any event of glucose p50 mg dl À1 during the first 10 days decreased the risk of severe ROP (OR 0.17 (0.06 to 0.51); P ¼ 0.02).
Collinearity was evaluated between TWGL and variables such as fungal and bacterial infections as well as steroid use to assure independence of those variables. Although 10 days TWGL and 30 days TWGL were similar between infants with and without fungal infections, infants with confirmed gram-positive infections, did show a greater 10 days TGWL (108 ± 15 versus 102 ± 22 mg dl À1 , P ¼ 0.04) and 30 days TWGL (103±12 versus 98±16 mg dl À1 , Table B ). Following that analysis, 30 days TWGL X118 mg dl À1 was identified as an independent predictor of severe ROP (OR 9.4 to 10, depending on the model, Table 2b ). To the contrary, any glucose level p50 mg dl À1 during the first 10 days of life was found to decrease the risk for severe ROP (OR 0.13 to 0.14, Table 2b ). In addition, confirmed sepsis (OR 4.1 to 4.5) and, specifically, gram-positive sepsis (OR 4.2 to 4.9) were also found predictive for severe ROP (Table 2b) .
Discussion
Abnormal glucose levels in ELBW infants
have not yet been defined. Data do not exist to establish appropriate normal ranges in premature infants and traditional definitions of hypo-and hyperglycemia based on statistical data in term newborns may not provide an appropriate basis for therapeutic decisions. Data obtained from percutaneous umbilical blood sampling in pregnant women at mid and late gestation suggest that normal mean fetal glucose levels are B85 and 75 mg dl À1 , respectively. 20 Adverse outcomes such as increased severity of ROP have been linked with high glucose levels in ELBW infants. 1, 9, 10 However, the infants in these studies also had a high severity of illness, making the results difficult to interpret. In this study, using our novel approach to analyze glucose data (TWGL) as a proxy for continuous glucose monitoring, we determined that in ELBW infants glucose levels currently considered within the normal range are linked to the development of severe ROP after correcting for the most significant demographic, perinatal and clinical factors. Although, severity of illness may contribute to glucose instability in ELBW infants, after logistic regression only >30 days TWGL and infection, mainly gram-positive sepsis, are independent predictors of severe ROP.
Using continuous glucose monitoring, Iglesias Platas et al. 21 have demonstrated that up to 60 and 50% of VLBW infants develop glucose levels X150 and p50 mg dl À1 , respectively; in our population of ELBW infants, the numbers were higher at 79 and 70%, respectively, perhaps reflecting the greater immaturity of our cohort. We have previously shown that average glucose levels are greater in ELBW infants developing ROP stage 3 or 4 with a risk that doubles for every 10 mg dl À1 increase in mean glucose levels. 10 Limitations in our previous study included the analysis of mean glucose levels, the small sample size, and the study design. Others have suggested a similar association between high glucose levels and ROP development in VLBW infants; however, because term newborn definitions of hyperglycemia were assumed and data were analyzed as binary categorical variables, the validity of the conclusions is limited. 1, 9 Currently ROP is recognized to be multifactorial and not exclusively linked to oxygen exposure. 22 Our current cohort of ELBW infants born between 2004 and 2007 were managed with more homogenous goal saturation parameters, likely explaining the similar maximum and average PaO 2 observed in infants with and without severe ROP. Retinopathy induced by oxygen and induced by diabetes share many pathophysiological similarities in both animal and human models. 23, 24 Vascular endothelial growth factor is implicated in the genesis of both disorders and is the therapeutic target of clinical trials to prevent ROP. 25, 26 In addition to vascular endothelial growth factor disturbances, other factors such as insulin-like growth factor-1 deficiency, could also be responsible for both, glucose instability and ROP. Insulin-like growth factor-1 deficiency is associated with glucose intolerance and frank diabetes which improves with replacement treatment 27 and relative insulin-like growth factor-1 deficiency, a common disturbance in VLBW infants, may also have a role in ROP development. 28, 29 Severity of ROP is also greater in infants developing more frequent episodes of hypoxemia which is another common event during the early life of ELBW infants. 30 Although animal studies suggest that early and acute disturbances in retinal circulation may occur after isolated episodes of high glucose, it is not clear whether retinopathy would develop after these episodes in the absence of exposure to excess oxygen. 31, 32 While retinal immaturity differentiates ELBW infants with ROP from adults with diabetic retinopathy, the similarities suggest that longitudinally stimulus, rather than an acute event, is more likely to result in ROP.
Glucose levels change constantly, making their analysis cumbersome and the main limitation of previous studies. As glucose values outside the 'normal' range would promote verification, more frequent testing will be performed around extreme values, skewing the results toward those extremes. To bypass this limitation, we apply a TWGL as a proxy for continuous glucose monitoring. 21, 33 A limitation of this approach is the need for as many data points as possible to increase accuracy and to refine the area under the curve. In this study, we analyzed a total of 51 171 glucose data points; of those two-thirds were bedside whole-blood glucose measurements. We have previously shown a direct correlation between these two methods, understanding the potential underestimation of the real value given by whole-blood method. 10 However, because elevated glucose values are underestimated, the use of whole-blood glucose would only attenuate the statistical relationship between elevated glucose and ROP.
Using the TWGL as our main approach to the glucose data, we have been able to clearly differentiate those infants developing severe ROP, as shown in Figure 2c , with the most significant separation between curves observed at around 10 days of life. Our preliminary analysis of the data as a continuous variable by logistic regression showed a 36% (P ¼ 0.04) and a 67% (P ¼ 0.01) increase in the risk for severe ROP for every 10 mg dl À1 increase in 10 days TGWL and 30 days TWGL, respectively (data not shown). Subsequent analysis based on the TWGL distribution using percentiles showed in our logistic regression adjusting for most demographic, perinatal and clinical factors that a 30 days TWGL X90th percentile (118 mg dl À1 ), value significantly lower than the suggested 150 mg dl À1 cutoff used to diagnose hyperglycemia in other studies, 1, 9 was associated with a 9-to 10-fold increase in the risk to develop severe ROP. In our study, single or multiple events of glucose levels X150 mg dl À1 were not predictors for severe ROP. In contrast, infants who had at least one event of a glucose level p50 mg dl À1 during the first 10 days of life were significantly less likely to develop severe ROP. In vitro studies have shown that similar to hypoxia low glucose concentrations may induce vascular endothelial growth factor mRNA stabilization, 34 which in turn could counterbalance the effect of retinal hyperoxia.
However, it is very likely that glucose levels p50 mg dl À1 are only a marker of better regulation of glucose homeostasis, due to more mature hormonal release patterns, higher insulin-like growth factor-1 levels or other factors not identified.
Extreme prematurity and oxygen exposure are the only two irrefutably accepted risk factors for ROP development. 6, 35 In addition to glucose status, which has been already discussed above, other factors such as exposure to higher mean airway pressure with prolonged mechanical ventilation, 10, 36 inotrope therapy, 10,36,37 and postnatal steroid administration 1, 38 as well the presence of a PDA, 39 BPD, 39 sepsis 37 and IVH 10 have been also linked to ROP development. Severity of illness is suspected to have a major role in the development of ROP, and potentially explains some of the significant associated factors. However, studies using CRIB score and score for neonatal acute physiology scores for evaluation of severity of illness, including this study, have resulted in contradictory findings with respect to risk for ROP. 9, 10 One limitation in the use of illness severity scores is that these observations are limited to the first 12 to 24 h after delivery; thus, the effects of events that occur later in the NICU course are not accounted for. We found that sepsis, specifically gram-positive infection, is linked to severe ROP. This may represent a direct effect of cytokines released during infection, but more likely is a marker for infants with central catheters in place for prolonged periods because of illness severity as suggested by Hartel et al. 40 We do acknowledge certain limitations in our study, most of them related to the retrospective nature of the data. Events of hyperoxia/hypoxia during the NICU course after the first 10 days of life could be linked to the development of severe ROP. 35 Therefore, the inability to further explore PaO 2 levels beyond the restricted period of time included in our analysis should be considered. Another limitation is created by the potential interactions between infections, steroid use and TWGL and the lack of longitudinal data. After adjusting for sepsis and steroids, TWGL still remained a significant independent predictor in the multivariate logistic regression even in those models where 'steroid' variables were removed. However, despite our efforts to evaluate for multicollinearity between these variables, we acknowledge that it is still possible that those interactions exist.
Conclusion
Disturbances in glucose homeostasis are prevalent in ELBW infants.
1,2 However, definitions for hypo-and hyperglycemia in this population are still not available. Although ROP has been linked to events of glucose levels X150 mg dl À1 (ref. 1, 9) , no clear biological background supports the concept that single events of high glucose can trigger the pathological process. In this study, we demonstrate in our cohort of ELBW infants that the frequency of events X150 mg dl À1 is not different in those infants developing severe ROP; furthermore, the length as well as the number of those events are not significantly different. Instead, we found that the overall glycemic status (TWGL) X118 mg dl À1 (90th percentile) throughout the first 30 days of life is a predictor for development of severe ROP.
Despite our efforts to clarify the link between severity of illness and ROP progression, it is still unclear how much influence this factor has. Certain factors such as sepsis, specifically gram-positive infections, and likely hypotension and steroid use may partially represent severity of illness. This study confirms the association between higher glucose levels and ROP progression; however, further clarification of the mechanisms responsible for this association will require larger prospective studies that control for clinical factors linked to severity of illness, as well as further studies in animal models.
